Praxis Precision Medicines (PRAX) News Today $33.55 -5.05 (-13.08%) Closing price 04:00 PM EasternExtended Trading$33.54 0.00 (-0.01%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Praxis Precision Medicines (NASDAQ:PRAX) Price Target Lowered to $85.00 at Truist FinancialTruist Financial dropped their price objective on Praxis Precision Medicines from $175.00 to $85.00 and set a "buy" rating on the stock in a research note on Monday.March 3 at 11:32 AM | marketbeat.comPraxis Precision price target lowered to $65 from $111 at Deutsche BankMarch 3 at 9:20 AM | markets.businessinsider.comAssessing Praxis Precision Medicine: Insights From 5 Financial AnalystsMarch 3 at 9:20 AM | benzinga.comPraxis Precision price target lowered to $85 from $150 at NeedhamMarch 3 at 9:20 AM | markets.businessinsider.comPraxis Precision Medicines (NASDAQ:PRAX) Price Target Cut to $85.00 by Analysts at Needham & Company LLCNeedham & Company LLC dropped their price objective on Praxis Precision Medicines from $150.00 to $85.00 and set a "buy" rating for the company in a research note on Monday.March 3 at 8:21 AM | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock PriceHC Wainwright cut their target price on shares of Praxis Precision Medicines from $120.00 to $105.00 and set a "buy" rating for the company in a research report on Monday.March 3 at 8:21 AM | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Price Target Lowered to $73.00 at Robert W. BairdRobert W. Baird dropped their price target on Praxis Precision Medicines from $117.00 to $73.00 and set an "outperform" rating for the company in a research note on Monday.March 3 at 8:21 AM | marketbeat.comPraxis Precision price target lowered to $85 from $175 at TruistMarch 1 at 6:35 PM | markets.businessinsider.comPraxis Precision Medicines (NASDAQ:PRAX) Issues Quarterly Earnings ResultsPraxis Precision Medicines (NASDAQ:PRAX - Get Free Report) posted its quarterly earnings results on Friday. The company reported ($2.94) EPS for the quarter, missing the consensus estimate of ($2.76) by ($0.18). Praxis Precision Medicines had a negative net margin of 9,409.22% and a negative return on equity of 54.86%.March 1 at 2:47 PM | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down After Earnings MissPraxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down on Disappointing EarningsMarch 1 at 10:12 AM | marketbeat.comPraxis Precision downgraded to Underperform at Wedbush after ET setbackMarch 1 at 9:40 AM | markets.businessinsider.comPraxis shares slump as committee says drug trial unlikely to meet main goalMarch 1 at 9:40 AM | reuters.comMarket Whales and Their Recent Bets on PRAX OptionsMarch 1 at 9:40 AM | benzinga.comPraxis Precision price target lowered to $61 from $114 at TD CowenMarch 1 at 9:40 AM | markets.businessinsider.comPraxis Precision provides corporate updates, anticipated milestonesFebruary 28 at 11:19 AM | markets.businessinsider.comPraxis Precision reports Q4 EPS ($2.94), consensus ($2.82)February 28 at 11:19 AM | markets.businessinsider.comPraxis to advance late-stage program for lead asset despite doubts over successFebruary 28 at 11:19 AM | msn.comPraxis Precision: Panel Recommends Stopping Essential Tremor Study for FutilityFebruary 28 at 11:19 AM | marketwatch.comPraxis' tremor drug trial unlikely to meet main goalFebruary 28 at 11:19 AM | msn.comPraxis Precision Medicines Shares Slide on Study SetbackFebruary 28 at 11:19 AM | marketwatch.comPraxis Precision Medicines Provides Update on Essential3 and Corporate UpdateFebruary 28 at 8:00 AM | globenewswire.comPraxis Precision Medicines (PRAX) Projected to Post Earnings on TuesdayPraxis Precision Medicines (NASDAQ:PRAX) will be releasing earnings before the market opens on Tuesday, March 4.February 25, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 8.5% - Here's What HappenedPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 8.5% - Time to Sell?February 24, 2025 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Rating of "Moderate Buy" by BrokeragesShares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) have received an average rating of "Moderate Buy" from the ten analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and nine haveFebruary 23, 2025 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock Position Lessened by Hussman Strategic Advisors Inc.Hussman Strategic Advisors Inc. decreased its holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,500 shares of the company's stock after selliFebruary 22, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 4.9% - Here's What HappenedPraxis Precision Medicines (NASDAQ:PRAX) Trading 4.9% Higher - What's Next?February 20, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Trading Down 8.6% - Here's What HappenedPraxis Precision Medicines (NASDAQ:PRAX) Trading Down 8.6% - Here's WhyFebruary 19, 2025 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Acquired by CIBC Asset Management IncCIBC Asset Management Inc raised its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 47.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 366,756 shares of the company'sFebruary 18, 2025 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Sees Large Increase in Short InterestPraxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,620,000 shares, an increase of 28.4% from the January 15th total of 2,040,000 shares. Based on an average trading volume of 377,300 shares, the short-interest ratio is presently 6.9 days. Approximately 15.2% of the company's shares are sold short.February 17, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Sets New 12-Month High - Should You Buy?Praxis Precision Medicines (NASDAQ:PRAX) Hits New 1-Year High - Should You Buy?February 15, 2025 | marketbeat.comPRAX stock soars to 52-week high, hits $90.33 amid robust gainsFebruary 14, 2025 | msn.comDeutsche Bank Initiates Coverage of Praxis Precision Medicines (PRAX) with Buy RecommendationFebruary 12, 2025 | msn.com4PRAX : What the Options Market Tells Us About Praxis Precision MedicineFebruary 12, 2025 | benzinga.comPraxis Precision Medicines (NASDAQ:PRAX) Trading Down 6.5% - Time to Sell?Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 6.5% - Should You Sell?February 11, 2025 | marketbeat.comPraxis Precision initiated with a Buy at Deutsche BankFebruary 11, 2025 | markets.businessinsider.comDeutsche Bank sets $111 target for Praxis Precision sharesFebruary 11, 2025 | msn.comPraxis Precision Medicines (NASDAQ:PRAX) Now Covered by Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft assumed coverage on shares of Praxis Precision Medicines in a research note on Tuesday. They set a "buy" rating and a $111.00 target price for the company.February 11, 2025 | marketbeat.comNeedham & Company LLC Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX)Needham & Company LLC reiterated a "buy" rating and set a $150.00 price objective on shares of Praxis Precision Medicines in a report on Monday.February 10, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Hits New 52-Week High - Still a Buy?Praxis Precision Medicines (NASDAQ:PRAX) Sets New 52-Week High - What's Next?February 5, 2025 | marketbeat.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 4, 2025 | globenewswire.comPraxis Precision Medicines (NASDAQ:PRAX) Trading Up 5.8% - Should You Buy?Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 5.8% - Still a Buy?February 3, 2025 | marketbeat.comPraxis Precision Medicines to Present at Two February Investor ConferencesFebruary 3, 2025 | globenewswire.comChina Universal Asset Management Co. Ltd. Invests $304,000 in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)China Universal Asset Management Co. Ltd. bought a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 3,952 shares of the company's stock, valued at approximatFebruary 3, 2025 | marketbeat.comPiper Sandler Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)February 1, 2025 | markets.businessinsider.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of "Moderate Buy" from AnalystsPraxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine analysts that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and eight have assigned aJanuary 29, 2025 | marketbeat.comJefferies maintains Praxis stock with $305 target, bullish on catalystsJanuary 22, 2025 | msn.comTruist Financial Releases a Buy Rating on Praxis Precision Medicines (PRAX)January 21, 2025 | markets.businessinsider.comTD Cowen Sticks to Their Buy Rating for Praxis Precision Medicines (PRAX)January 21, 2025 | markets.businessinsider.comExpert Outlook: Praxis Precision Medicine Through The Eyes Of 5 AnalystsJanuary 21, 2025 | benzinga.comTruist raises Praxis stock target to $175 on study optimismJanuary 21, 2025 | msn.com Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address PRAX Media Mentions By Week PRAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAX News Sentiment▼0.060.71▲Average Medical News Sentiment PRAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAX Articles This Week▼305▲PRAX Articles Average Week Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TG Therapeutics News Today SpringWorks Therapeutics News Today Organon & Co. News Today Ultragenyx Pharmaceutical News Today PTC Therapeutics News Today ADMA Biologics News Today Avidity Biosciences News Today Zai Lab News Today Biohaven News Today Alvotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAX) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRAX Stock Alerts